Huang, J., Chen, A., Jin, H., Liu, F., Hei, G., Teng, Z., Xiao, J., Wu, R., Zhao, J., Davis, J. M., Shao, P., & Smith, R. C. (2025). Efficacy and Safety of Sulforaphane Added to Antipsychotics for the Treatment of Negative Symptoms of Schizophrenia. The Journal of Clinical Psychiatry, 86(1). https://doi.org/10.4088/jcp.24m15272

Dall’Era, M., Kalunian, K., Solomons, N., Truman, M., Hodge, L. S., Yap, E., & Askanase, A. D. (2024). Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS. Lupus Science & Medicine, 11(2), e001319. https://doi.org/10.1136/lupus-2024-001319

Liao, K. P., Rist, P., Giles, J., Santacroce, L., Connelly, M. A., Glynn, R. J., Ridker, P., Tawakol, A., Bathon, J., & Solomon, D. H. (2024). Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial. Arthritis Research & Therapy, 26(1). https://doi.org/10.1186/s13075-024-03352-3